PL4265242T3 - Kompozycja o wysokiej dawce kwasu traneksamowego i sposób jej wytwarzania - Google Patents
Kompozycja o wysokiej dawce kwasu traneksamowego i sposób jej wytwarzaniaInfo
- Publication number
- PL4265242T3 PL4265242T3 PL23154522.9T PL23154522T PL4265242T3 PL 4265242 T3 PL4265242 T3 PL 4265242T3 PL 23154522 T PL23154522 T PL 23154522T PL 4265242 T3 PL4265242 T3 PL 4265242T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- acid composition
- high dose
- tranexamic acid
- tranexamic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202211023210 | 2022-04-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4265242T3 true PL4265242T3 (pl) | 2026-02-23 |
Family
ID=85158378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL23154522.9T PL4265242T3 (pl) | 2022-04-20 | 2023-02-01 | Kompozycja o wysokiej dawce kwasu traneksamowego i sposób jej wytwarzania |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4265242B1 (pl) |
| KR (1) | KR102970592B1 (pl) |
| CN (1) | CN116898832A (pl) |
| BR (1) | BR102023006993A2 (pl) |
| ES (1) | ES3050159T3 (pl) |
| MX (1) | MX2023002172A (pl) |
| PL (1) | PL4265242T3 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025130650A (ja) * | 2024-02-27 | 2025-09-08 | アテナ ファーマシューティク エスエーエス | トラネキサム酸コーティング顆粒組成物及びその調製プロセス |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE327737T1 (de) * | 2001-03-07 | 2006-06-15 | Dainippon Sumitomo Pharma Co | Verfahren zur herstellung von arzneistoffgranulatkörnern, die arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische zubereitungen |
| US20090214644A1 (en) * | 2003-07-31 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations with reduced adverse effects |
| US8597683B2 (en) * | 2010-11-30 | 2013-12-03 | Watson Pharmaceuticals, Inc. | Modified release tranexamic acid formulation |
| WO2014195872A1 (en) * | 2013-06-04 | 2014-12-11 | Vyome Biosciences Pvt. Ltd. | Coated particles and compositions comprising same |
-
2023
- 2023-02-01 PL PL23154522.9T patent/PL4265242T3/pl unknown
- 2023-02-01 EP EP23154522.9A patent/EP4265242B1/en active Active
- 2023-02-01 ES ES23154522T patent/ES3050159T3/es active Active
- 2023-02-13 CN CN202310140643.5A patent/CN116898832A/zh active Pending
- 2023-02-21 MX MX2023002172A patent/MX2023002172A/es unknown
- 2023-04-13 BR BR102023006993-2A patent/BR102023006993A2/pt unknown
- 2023-04-14 KR KR1020230049558A patent/KR102970592B1/ko active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES3050159T3 (en) | 2025-12-19 |
| MX2023002172A (es) | 2023-10-23 |
| EP4265242A1 (en) | 2023-10-25 |
| EP4265242C0 (en) | 2025-09-03 |
| BR102023006993A2 (pt) | 2023-10-24 |
| KR102970592B1 (ko) | 2026-05-28 |
| KR20230149737A (ko) | 2023-10-27 |
| EP4265242B1 (en) | 2025-09-03 |
| CN116898832A (zh) | 2023-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202306105B (en) | Heart-nourishing and nerve-soothing pharmaceutical composition and method for preparation thereof and application thereof | |
| EP4596529A4 (en) | IONIZABLE CATIONIC LIPID COMPOUND AND COMPOSITION FOR THE ADMINISTRATION OF NUCLEIC ACID AND ITS USE | |
| MX2008013782A (es) | Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen. | |
| MY202371A (en) | Hexone glucokinase inhibitor and use thereof | |
| EP4231838A4 (en) | MEAT SUBSTITUTE COMPOSITION AND METHOD FOR ITS PRODUCTION | |
| HUP0303347A3 (en) | Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis polymorphonucleate and mononucleate cells, process for their preparation and pharmaceutical compositions containing them | |
| WO2019224790A3 (en) | Prodrugs of fulvestrant | |
| EP4302778A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-TSLP ANTIBODY | |
| MX2012008413A (es) | Composicion novedosa de retigabina. | |
| PL3992177T3 (pl) | Nowatorska pochodna kwasu aminoalkanowego, zawierająca w swojej strukturze ugrupowanie bifenylowe, oraz kompozycja farmaceutyczna o działaniu przeciwgrzybiczym, w skład której wchodzi ta pochodna | |
| MX2026001837A (es) | Compuestos que contienen ciclobutilo | |
| WO2021100029A3 (en) | Prodrugs of fulvestrant | |
| GB202010464D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
| EP3960167A4 (en) | Use of pantothenic acid in preparation composition for treating and/or preventing tumors | |
| AU2022214501A9 (en) | Pharmaceutical composition for treating liver diseases using ssu72 | |
| MX2023014776A (es) | Sales de sulcardina. | |
| IL314565A (en) | Pharmaceutical preparations for pain treatment | |
| SG11202007228WA (en) | Method for suppressing discoloration of external composition containing adenosine phosphate and tranexamic acid | |
| EP4265242C0 (en) | COMPOSITION OF HIGH-DOSE TRANEXAMIC ACID AND ITS PREPARATION PROCESS | |
| PH12021551760A1 (en) | Amino acid derivatives for the treatment of inflammatory diseases | |
| GB2592737B (en) | Material composition and process for preparation thereof | |
| EP4620468A4 (en) | BUTADIENE-CYCLODEXTRIN INCLUSION COMPLEX, PHARMACEUTICAL COMPOSITION, PROCESS OF PREPARATION AND ASSOCIATED USE | |
| EP4424763A4 (en) | Composition of polyamic acid and its preparation process | |
| GEAP201813784A (en) | Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
| GB202303005D0 (en) | Insecticidal composition and process for preparation thereof |